Fragile x syndrome|https://phgkb.cdc.gov/GAPPKB/phgHome.do|Fragile x syndrome

https://phgkb.cdc.gov/GAPPKB/phgHome.do

From From Genomics & Health Impact Scan Database

This database includes published scientific literature on evidence-based translation of genomic discoveries into improved health care and disease prevention that have a potential impact on population health.

---

• The Future of Fragile X Syndrome: CDC Stakeholder Meeting Summary  
  C Riley et al, Pediatrics, June 2017
• Parental Perspectives on Pharmacological Clinical Trials: a Qualitative Study in Down Syndrome and Fragile X Syndrome.  
  Reines Victoria et al. Journal of genetic counseling 2017 May
• Do the data really support ordering fragile X testing as a first-tier test without clinical features?  
  Weinstein Veronique et al. Genetics in medicine : official journal of the American College of Medical Genetics 2017 May
• Identification of fragile X pre-mutation carriers in the Chinese obstetric population using a robust FMR1 polymerase chain reaction assay: implications for screening and prenatal diagnosis.  
  Cheng Y Ky et al. Hong Kong medical journal = Xianggang yi xue za zhi 2017 Mar
• A 15-year-long Southern blotting analysis of FMR1 to detect female carriers and for prenatal diagnosis of fragile X syndrome in Taiwan.  
  Tzeng Ching-Cherng et al. Clinical genetics 2017 Jan

more